Global immunoglobulin market Expected to Progress at $21.49 Billion by 2028

July 22 04:06 2022
Global immunoglobulin market Expected to Progress at $21.49 Billion by 2028
Immunoglobulin Market
According to Triton’s research report, the immunoglobulin market attained $13.61 billion in 2021. It is further anticipated to register a CAGR of 6.77% by 2028.

A recent study by Triton Market Research titled Global Immunoglobulin Market includes the global market outlook by Delivery Mode (Intramuscular, Subcutaneous, Intravenous), Type (IgA, IgM, IgE, IgD, IgG), by Application (Hypogamma Globulienemia, Chronic Inflammatory Demyelinating Polyneuropathy, Myasthenia Gravis, Idiopathic Thrombocytopenic Purpura, Specific Antibody Deficiency, Guillain-Barre Syndrome, Primary Immunodeficiency Diseases, Inflammatory Myopathies, Multifocal Motor Neuropathy, Other Applications), Sales Channel (Hospital Pharmacy, Specialty Pharmacy, Other Sales Channels), End-user (Hospital and Clinics, Homecare), and Geography (North America, Middle East and Africa, Latin America, Europe, Asia-Pacific).

Immunoglobulin helps reduce the risk of life-threatening infections for people experiencing immune-related conditions. Moreover, immunoglobulin therapy significantly enhances prognosis and quality of life and antibiotic use, promoting better pediatric population growth and maintaining normal pulmonary function. 

 

Request a Free Sample of the Global Immunoglobulin Market Report @ https://www.tritonmarketresearch.com/reports/immunoglobulin-market#request-free-sample

 

Triton Market Research’s report shows that the global immunoglobulin market is expected to grow at a CAGR of 6.77%, reaching a revenue worth $21.49 billion by 2028.

Around the globe, the occurrence of immune deficiency disorders and the severity of some illnesses are more likely to affect the aged population. Therefore, the rising geriatric population, the prevalence of immunodeficiency and autoimmune disorders, and the increasing R&D activities are expected to increase the demand for immunoglobulin products. This factor, in turn, will supplement the market growth during the forecast period. 

However, the high cost of immunoglobulin therapy and the side effects due to its use can hinder the market’s growth.

The Immunoglobulin market is divided into type, delivery mode, application, end-user, and sales channel. The type segment includes IgA, IgM, IgE, IgD, and IgG. Based on the delivery mode, the segment is branched into intramuscular, intravenous and Subcutaneous. The application segment is divided into hypogamma globulienemia, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, idiopathic thrombocytopenic purpura, specific antibody deficiency, guillain-barre syndrome, primary immunodeficiency diseases, inflammatory myopathies, multifocal motor neuropathy, and other applications. Further, end-users include hospitals & clinics and homecare. And at last, the sales channel comprises hospital pharmacy, specialty pharmacy, and other sales channels. 

North America leads the immunoglobulin market globally. The region’s market is growing due to the high prevalence of the different types of immunodeficiency diseases across the United States and Canada. Further, the increase in product approvals by the United States Food and Drug Administration is expected to boost the demand for immunoglobulin products. Product development and technological advancement have also accelerated the scope of innovation in the region. 

The established firms in the global immunoglobulin market are Biotest AG, Kedrion Biopharma, Grifols SA, CSL Behring, Octapharma AG, Bio Products Laboratory, Shanghai Raas Blood Products Co Ltd, Adma Biologics, Kamada Ltd, LFB Group, Sichuan Yuanda Shuyang Sanquin Plasma Products BV, Pharmaceutical Co Ltd, Takeda Pharmaceutical Company Limited, and China Biologic Products Inc. 

 

Purchase this Report @ https://www.tritonmarketresearch.com/reports/immunoglobulin-market#purchase-option

 

Question and Answer: Immunoglobulin Market 

Question 1: Which factors supplement the immunoglobulin market growth?

Answer: Around the globe, the occurrence of immune deficiency disorders and the severity of some illnesses are more likely to affect the aged population. Therefore, the rising geriatric population, the prevalence of immunodeficiency and autoimmune disorders, and the increasing R&D activities are expected to increase the demand for immunoglobulin products. This factor, in turn, will supplement the market growth during the forecast period. 

Question 2: What factors hinder the immunoglobulin market’s growth?

Answer: The high cost of immunoglobulin therapy and the side effects due to its use can hinder the market’s growth.

Question 3: Which region leads the immunoglobulin market?

Answer: North America leads the immunoglobulin market globally. The region’s market is growing due to the high prevalence of the different types of immunodeficiency diseases across the United States and Canada. Further, the increase in product approvals by the United States Food and Drug Administration is expected to boost the demand for immunoglobulin products. Product development and technological advancement have also accelerated the scope of innovation in the region. 

Question 4: Which are the established firms in the global immunoglobulin market??

Answer: The established firms in the global immunoglobulin market are Biotest AG, Kedrion Biopharma, Grifols SA, CSL Behring, Octapharma AG, Bio Products Laboratory, Shanghai Raas Blood Products Co Ltd, Adma Biologics, Kamada Ltd, LFB Group, Sichuan Yuanda Shuyang Sanquin Plasma Products BV, Pharmaceutical Co Ltd, Takeda Pharmaceutical Company Limited, and China Biologic Products Inc. 

 

Related Report:

Global Blood Plasma Market 

The Global Blood Plasma Market is expected to grow at a CAGR of 6.13% during the forecasted period 2019-2027. 

With the emerging primary and secondary immunodeficiencies, checking blood plasma levels in immunocompromised patients has become essential. The increasing public cognizance, rise in plasma products, and the occurrences of hemophilia are major factors fueling the blood plasma market’s growth globally. 

However, the spread of pathogenic contaminants and high regulations are major restraining factors negatively impacting the studied market’s development. 

 

About Us:

We are a leading market research company with offices in the UK, providing our clients with the best online market research and data search reports.

 

Contact Us:

Triton Market Research

196, wards wharf approach

London E16 2EQ

Phone:  +44 7441 911839

Email:  [email protected]

Media Contact
Company Name: Triton Market Research
Contact Person: Matt Dixson
Email: Send Email
Phone: +44 7441 911839
Address:196, wards wharf approach London E16 2EQ
Country: United Kingdom
Website: https://www.tritonmarketresearch.com/